TMC435
Drug timelines are a Plus or Pro feature.
36 regulatory and trial events tracked for TMC435, covering 2010-04-28 to 2017-07-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected Patients [Phase 3]